Microbiome Analysis for Inflammatory Bowel Disease (IBD)

About inbiome

inbiome is a private, pre-revenue diagnostics company developing a revolutionary bacterial identification platform called Molecular Culture®. This technology combines proprietary chemistry and AI to detect all bacterial species in a sample within hours, overcoming the limitations of traditional culture and PCR methods. Initially optimized for joint aspirate analysis in infectious disease diagnostics, the platform has broad potential across infectious diseases and microbiome-based healthcare. The company collaborates with academic and clinical partners to validate and commercialize its technology, aiming to shift healthcare towards faster diagnostics and preventive strategies.

Therapeutic Areas